v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 05, 2026
Mar. 30, 2025
Operating activities:    
Net income $ 40,718 $ 42,237
Loss (income) from discontinued operations, net of income taxes 175 (568)
Income from continuing operations 40,893 41,669
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:    
Restructuring and other costs 10,675 3,239
Depreciation and amortization 105,056 97,422
Gain on disposition of businesses and assets, net (5,074) 0
Stock-based compensation 8,715 7,731
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) (99) (625)
Amortization of deferred debt financing costs and accretion of discounts 1,139 1,102
Change in fair value of financial securities 4,204 (3,073)
Unrealized Foreign Exchange (Gain) Loss Related to Proceed from Sale of Business 100 (66)
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:    
Accounts receivable, net 61,547 18,140
Inventories (12,838) (5,486)
Accounts payable (13,744) 8,854
Increase (Decrease) in Accrued Expenses and Other (74,687) (34,810)
Net cash provided by operating activities of continuing operations 125,887 134,097
Net cash used in operating activities of discontinued operations (10,657) (5,942)
Net cash provided by operating activities 115,230 128,155
Investing activities:    
Capital expenditures (19,775) (15,982)
Purchases of investments and notes receivables (1,055) 0
Proceeds from investments and notes receivables 677 0
Proceeds from disposition of property, plant and equipment 9,003 0
Proceeds from disposition of businesses and assets 158 229
Cash paid for acquisitions, net of cash acquired (67,280) 0
Net cash used in investing activities of continuing operations (78,272) (15,753)
Net cash provided by investing activities of discontinued operations 0 9,375
Net cash used in investing activities (78,272) (6,378)
Financing activities:    
Payments of debt financing issuance costs 0 (2,402)
Net payments on other credit facilities 0 (50)
Payment for Contingent Consideration Liability, Financing Activities 0 (1,817)
Proceeds from issuance of common stock under stock plans 5,441 2,632
Purchases of common stock (86,496) (153,594)
Dividends paid (7,840) (8,433)
Net cash used in financing activities (88,895) (163,664)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (7,627) 16,122
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent (59,564) (25,765)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period 921,030 1,164,452
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period 861,466 1,138,687
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 860,320 1,137,620
Restricted Cash, Current 428 1,067
Restricted Cash, Noncurrent 718 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 861,466 $ 1,138,687